October 6, 2022: In our public comment to the EPA, the National Center for Health Research agrees with EPA’s proposed designation of PFOA and PFOS as CERCLA hazardous substances. Holding companies accountable for these toxic chemicals, and other PFAS chemicals, will improve human health.
Read More »On Health Policy
Testimony of Diana Zuckerman at the Meeting of EPA’s National Environmental Justice Advisory Council on September 28, 2022
September 28, 2022: I want to comment very briefly on the PFAS recommendations, since that’s an issue we’ve worked on for years. Let me add that we are very concerned about all endocrine disrupting chemicals not just PFAS.
Read More »NCHR Letter to Sen. Smith in Support of Women’s Health Legislation
September 22, 2022: Two bills led by Sen. Smith take critical steps to help protect access to safe and effective reproductive health care products. We at NCHR are appreciative of her work to act in the face of the many challenges presented following the Dobbs decision.
Read More »NCHR Comments on the CMS National Coverage Analysis of Seat Extenders for Wheelchairs
September 14, 2022: We strongly support the coverage of wheelchair seat extender systems through Medicare and encourage CMS quickly act on this decision. There are numerous direct medical benefits from the use of power seat elevation systems in power wheelchairs. Many preventable complications and secondary conditions are common among individuals who spend long periods of time unable to stand or walk, restricted to a bed, chair, or wheelchair.
Read More »NCHR Comments on the Calendar Year 2023 Medicare Physician Fee Schedule
September 8, 2022: We are encouraged to see policies in this Proposed Rule that would increase access to quality healthcare for millions of vulnerable Americans. NCHR supports the proposal for continued expansion of coverage for telemental health services. We also support the provision to cover substance use disorder (SUD) for Medicare beneficiaries.
Read More »